DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Dummer R, Ascierto PA, Gogas HJ. et al.
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial.
Lancet Oncol 2018;
19: 603-615
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.